The choice of which GLP-1 is best for diabetes treatment will depend on factors like patient preference with injection frequency, individual tolerance of potential side effects, overall effectiveness in managing blood sugar levels, and insurance coverage
A new class of very small proteins (30 or fewer amino acids, and perhaps better named polypeptides) called smORFs (small open reading frames) has recently been discovered to have significant biological activity
For serum samples, 75 L of chloroform:methanol extraction solvent (v:v = 1:2) was added to 20 L of mouse serum, with the exception of the serum from WT, Gclc L-KO, Nrf2 L-KO, and L-DKO mouse serum, for which 20 L of mouse serum was combined with 180 L of chloroform:methanol extraction solvent (v:v = 1:2) containing internal standards at the final concentrations: 5 nM D7-Sphinganine (Avanti Polar Lipids Inc., Cat# 860658), 12.5 nM D3-Deoxysphinganine (Avanti Polar Lipids Inc., Cat# 860474), and SPLASH LIPIDOMIX (1:1000, Avanti Polar Lipids Inc., Cat# 330707)
GLP1 receptor agonists have been shown to reduce hemoglobin A1c (a roughly three-month sugar average) by approximately 1% compared to control groups in patients with type 2 diabetes
IR contributed with good practices of the clinical trial regulations